Outcomes After Initial Noninterventional Management of Clinical Stage cT1b Renal Masses
In this report, we looked at the outcomes of surveilling larger (cT1b) renal masses in a large population in Michigan. We found that watching instead of treating cT1b renal masses immediately in older people with more medical conditions did not change survival or cause the cancer to spread compared with people who were treated immediately. We conclude that surveillance for cT1b cancer is an option that should be considered for all patients but implemented selectively.
Authors
- Craig Rogers (ORCID: https://orcid.org/0000-0002-7781-6644)
- Stephanie Daignault‐Newton (ORCID: https://orcid.org/0000-0001-6355-0710)
- Brian R. Lane (ORCID: https://orcid.org/0000-0003-1084-1519)
- Mohit Butaney (ORCID: https://orcid.org/0000-0002-4760-4026)
- Alice Semerjian (ORCID: https://orcid.org/0000-0002-8031-993X)
- Sam Wilder
- Mahin Mirza
- Mackenzie Gammons
- Yuzhi Wang (ORCID: https://orcid.org/0000-0003-3552-1589)
- Bilal Hussain (ORCID: https://orcid.org/0000-0002-2885-2999)
- Amit Patel (ORCID: https://orcid.org/0000-0002-1409-7558)
- Monica Van Til
- Abena Osei
- Jack Considine
Institutions
- Grand Rapids Community College (US)
- University of Michigan (US)
- Corewell Health
- Michigan State University (US)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1016/j.euros.2025.09.008
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00